Doctors hail drug that spares bladder cancer patients ‘life-changing’ surgery
A clinical trial led by the Institute of Cancer Research has found that the immunotherapy drug durvalumab can help bladder cancer patients avoid life-changing surgery. The treatment, when combined with chemotherapy and radiotherapy, significantly reduces the risk of cancer recurrence.
Why it matters
This medical advancement offers a less invasive alternative to radical surgery, potentially improving the quality of life for thousands of bladder cancer patients.
The artist Tracey Emin has spoken about the impact on her life of surgery she received after a diagnosis of bladder cancer in 2020. Photograph: Marissa Davison/Reuters View image in fullscreen The artist Tracey Emin has spoken about the impact on her life of surgery she received after a diagnosis of bladder cancer in 2020. Photograph: Marissa Davison/Reuters Cancer research Doctors hail drug that spares bladder cancer patients ‘life-changing’ surgery Durvalumab shows promising results in trial led by London-based Institute of Cancer Research
The report is a straightforward summary of medical research findings presented at a conference.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in